scorecardresearch
Add as a preferred source on Google
Tuesday, April 7, 2026
TopicBPPI

Topic: BPPI

Modi govt’s affordable medicines scheme fails second audit in less than a year

A second audit of the Pradhan Mantri Bharatiya Janaushadhi Pariyojana finds several irregularities, a year after the government's own auditors found lapses.

No one to control quality, jan aushadhi forced to recall 6 batches of drugs in 3 months

Centre’s flagship scheme for affordable medicines has been under a cloud, with allegations of fraud, and top officials’ resignations.

Govt orders immediate audit after suspicion of scam in medicines-for-all scheme

An internal audit found many irregularities in the implementation of the PMBJP, and minister Mandaviya says he’s ordered another one to probe them.

Affordable drugs scheme in crisis: 3 CEOs quit in 3 years, no replacement found since

BPPI, the bureau that runs the Pradhan Mantri Bharatiya Janaushadhi Pariyojana, has been looking for a CEO since November last year.

On Camera

India must reduce its dependence on fertiliser imports before it’s too late

What worsens India’s dependence on fertiliser imports is not merely the volume of imports, but the inefficiency with which the country utilises them.

Syringes, MRI to ventilators, West Asia war squeezing India’s medical supply chain—costs up 10 to 50%

Industry says manufacturers have 2-4 weeks of buffer stocks, but prolonged disruption could push up shortage risks, especially of consumables like IV and syringes.

UAE walks away from financing Rafale F5 due to restricted access to technology, reports French media

French newspaper La Tribune earlier last week indicated that UAE withdrew from deal to fund EUR 3.5 billion. India is looking to order 114 new Rafales, which could include the F5.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.